Success Stories: NIW Approved in 12 Days: PhD Student in Biotechnology Benefits from Premium Processing
Client’s Testimonial:
“Thanks to the NAILG group for the assistance!”
On April 1st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD student in the Field of Biotechnologies (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: PhD Student
Country of Origin: Iran
State of Residence at the Time of Filing: New York
Approval Notice Date: April 1st, 2025
Processing Time: 12 days (Premium Processing Requested)
Case Summary:
A promising Ph.D. student recently received NIW approval for his groundbreaking research in microfluidic technology, work that is helping redefine how diseases are studied and treated. Specializing in the development of advanced microfluidic systems that integrate precision micro-fabrication with high-resolution imaging, he is creating tools that replicate the complex microenvironments of the human body. These systems offer researchers a powerful way to observe how cells behave in realistic conditions, revealing mechanisms of disease progression and enabling the design of more effective, personalized therapies for conditions such as cancer, neurodegenerative disorders, and antibiotic-resistant infections.
The North America Immigration Law Group (NAILG) was honored to support his petition, recognizing the clear national importance of his research in advancing biomedical innovation and public health.
Although still early in his career, our client has already made meaningful contributions to the scientific community:
● Authored four peer-reviewed journal articles, including two as first author
● Received 30 citations, highlighting the growing recognition of his work in the academic field
His research directly addresses a major challenge in modern medicine: the need to analyze and influence cell behavior within biologically relevant environments. By offering a scalable, high-precision platform for studying disease at the cellular level, his work is helping accelerate drug discovery and refine therapeutic approaches in a way that supports the broader mission of personalized medicine.
One of his expert recommenders wrote:
“Altogether, [client’s] leadership in biotechnology is evident through his groundbreaking research on microfluidic systems, including optimizing ECRs for high-efficiency particle separation and developing Asym-CEMC bacteria removal. His contributions have improved lab-on-a-chip applications, improved cancer diagnostics, and enhanced bioprocessing methods. These achievements underscore his ability to deliver impactful innovations. Thus, there is no doubt that [client] shall continue driving progress in biotechnology, yielding meaningful benefits for both national and global scientific and healthcare priorities.”
Our legal team at NAILG crafted a compelling NIW petition that clearly outlined the national relevance and real-world applications of his work. We are proud to have played a role in this successful outcome and look forward to the continued impact he will make in biomedical research and innovation.

